NCT06133192View on ClinicalTrials.gov

Steroids Versus ECP and Steroids as First-line Treatment of Grade II Acute GVHD

PHASE2Not yet recruitingINTERVENTIONAL

Enrollment

42

Participants

Timeline

Start Date

January 31, 2024

Primary Completion Date

September 30, 2025

Study Completion Date

January 31, 2026

Conditions

Graft Vs Host Disease

Interventions

DRUG

Uvadex

Uvadex use for ECP

DRUG

Steroids

steroids 2 mg/kg/d

Trial Locations (1)

54511

CHRU de Nancy, Vandœuvre-lès-Nancy

All Listed Sponsors

lead

Central Hospital, Nancy, France

OTHER